Evolus Inc (EOLS) - Yalpi foyda normasi

Evolus Corp (EOLS) kompaniyasining rasmiy ramzlari

Evolus, Inc. (EOLS) yagona, yuqori talabga ega neyrotoksinga e'tibor qaratgani sababli yuqori masshtablanish imkoniyatiga ega. Samarali raqamli marketing va rahbarlik tajribasi kompaniyaga daromadlilikni saqlash imkonini beradi, buni GURU.Markets portalidagi konsolidatsiyalashgan yalpi foyda marjasi tasdiqlaydi, u yerda 64.50 ushbu ko'rsatkichning joriy qiymatini belgilaydi. Kompaniya hozirda barqaror o'sishni boshdan kechirmoqda, dori vositasining klinik ko'rsatmalari doirasini kengaytirmoqda va zamonaviy sodiqlik dasturlarini joriy etmoqda.

EOLS Evolus Inc Yalpi rentabellik (04.07.2022 - 20.11.2026)

evolus.com (EOLS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:EOLS Evolus Inc
Evolus, Inc. asosiy tovari

Yalpi marja bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda ulushini belgilaydi va biznesning operatsion xarajatlar hamda kengayishni qoplash uchun resurslar yaratish qobiliyatini namoyish etadi. Biznesning yalpi marjalarini tahlil qilish Evolus, Inc. (EOLS) AI platformalarining kengayish samaradorligini baholash imkonini beradi, bunda estetik tibbiyotdagi buxgalteriya avtomatlashtirishi mijozlarga xizmat ko'rsatish xarajatlarini kamaytirishi va shu orqali emitentning fundamental barqarorligini oshirishi kerak.

Asosiy raqobatchilar

HCA Holdings (HCA) - Yalpi marja|THC (tenethealth.com) - Yalpi marja|Yalpi marja Fresenius Medical|Yalpi foyda bo'yicha rentabellik SOLV (Solventum Health)|Yalpi foyda bo'yicha sotuv rentabelligi Encompass Health Corporation|Universal Health Services - Yalpi foyda bo'yicha rentabellik|DVA - Yalpi foyda bo'yicha rentabellik|RadNet Management - Yalpi marja|Yalpi foyda normasi OPCH (Option Care Health Inc)|Surgery Partners, Inc. (SGRY) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Premier|EYE (National Vision Holdings, Inc.) - Yalpi marja|Progyny Inc (PGNY) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ARDT|Yalpi rentabellik SEM (Select Medical Inc.)|Yalpi marja ASTH (Astrana Health, Inc.)|Yalpi marja Pediatrix Corp MD|USPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Pennant Group Inc|organogenesis.com (ORGO) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Nutex Health Inc.|Yalpi rentabellik aunainvestors.com|SBC: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik CYH (Community Health Corp)|Yalpi foyda bo'yicha sotuv rentabelligi The Beauty Health Company|MediWound - Yalpi foyda bo'yicha rentabellik|Yalpi marja biote Corp. BTMD|JYNT: Yalpi foyda bo'yicha rentabellik|DocGo Inc. (DCGO) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi rentabelligi P3 Health Partners|Yalpi foyda bo'yicha rentabellik Gain Therapeutics|EUDA (euda.com) - Yalpi marja|BMGL - Sotuvning yalpi marjinal rentabelligi|Yalpi marja CLGN|Cuprina Holdings - Sotuvning yalpi rentabelligi|Yalpi marja CCM (Concord Medical Services Holdings)|Yalpi marja American Shared Hospital Services Inc AMS|MRM - Yalpi rentabellik|Avalon GloboCare Corp. - Yalpi foyda koeffitsiyenti|DHAI: Yalpi marja|Sotuvning yalpi rentabelligi XAGE|NIVF (NewGenIvf Group Limited) - Yalpi marja|Yalpi foyda marjasi ATI Physical Therapy ATIP|Yalpi rentabellik CareMax Medical Group (CMAX)|Yalpi marja Kindly MD Corp (KDLY)|Yalpi rentabellik ModivCare Inc MODV|Yalpi foyda koeffitsiyenti NVOS (novointegrated.com)|SSY - Yalpi rentabellik|BACK (IMAC Regeneration Centers) - Sotuvning yalpi rentabelligi